Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1492 participants
OBSERVATIONAL
2009-02-28
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Patients with hypertension and hyperlipidemia and other CV risk factors
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients received a cholesterol lowering treatment in addition to hypertension treatment during the observation period
* Patients received during the observation time new cholesterol lowering and hypertension treatment
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AstraZeneca Pharmaceuticals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Frick, Canton of Aargau, Switzerland
Research Site
Neuenhof, Canton of Aargau, Switzerland
Research Site
Riehen, Canton of Basel-City, Switzerland
Research Site
Thun, Canton of Bern, Switzerland
Research Site
Wynigen, Canton of Bern, Switzerland
Research Site
Geneva, Canton of Geneva, Switzerland
Research Site
Le Lignon, Canton of Geneva, Switzerland
Research Site
Meyrin, Canton of Geneva, Switzerland
Research Site
Schwyz, Canton of Schwyz, Switzerland
Research Site
Gerlafingen, Canton of Solothurn, Switzerland
Research Site
Lohn SO, Canton of Solothurn, Switzerland
Research Site
Zuchwil, Canton of Solothurn, Switzerland
Research Site
Rorschach, Canton of St. Gallen, Switzerland
Research Site
Sankt Gallen, Canton of St. Gallen, Switzerland
Research Site
Bassins, Canton of Vaud, Switzerland
Research Site
Gland, Canton of Vaud, Switzerland
Research Site
Lausanne, Canton of Vaud, Switzerland
Research Site
Montreux, Canton of Vaud, Switzerland
Research Site
Nyon, Canton of Vaud, Switzerland
Research Site
Zug, Canton of Zug, Switzerland
Research Site
Affoltern am Albis, Canton of Zurich, Switzerland
Research Site
Feldmeilen, Canton of Zurich, Switzerland
Research Site
Herrliberg, Canton of Zurich, Switzerland
Research Site
Langnau am Albis, Canton of Zurich, Switzerland
Research Site
Richterswil, Canton of Zurich, Switzerland
Research Site
Rüti, Canton of Zurich, Switzerland
Research Site
Zurich, Canton of Zurich, Switzerland
Research Site
Arbedo, Canton Ticino, Switzerland
Research Site
Bellinzona, Canton Ticino, Switzerland
Research Site
Claro, Canton Ticino, Switzerland
Research Site
Coldrerio, Canton Ticino, Switzerland
Research Site
Locarno, Canton Ticino, Switzerland
Research Site
Lugano, Canton Ticino, Switzerland
Research Site
Muralto, Canton Ticino, Switzerland
Research Site
Andeer, Kanton Graubünden, Switzerland
Research Site
Ilanz, Kanton Graubünden, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-CCH-DUM-2008/2
Identifier Type: -
Identifier Source: org_study_id